TINAGL1 and triple-negative breast carcinoma: In contrast, another study that also focused on the role of TINAGL1 in cancer metastasis showed lower TINAGL1 expression correlates with advanced triple-negative breast cancer tumor stages, reduced disease-free survival, and distant metastasis-free survival [47].